These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6334679)

  • 21. A comparison of cefamandole, cefoxitin, cefuroxime, cefotaxime and cefoperazone: an in vitro test on a number of beta-lactamase producing strains of 9 species and 1 genus of bacteria.
    Kuipers JS
    Curr Med Res Opin; 1981; 7(3):196-203. PubMed ID: 6971210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
    Okonogi K; Harada S; Shinagawa S; Imada A; Kuno M
    J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Parallel resistance between cephalosporins and penicillins].
    Grimm H
    Arzneimittelforschung; 1984; 34(1):62-5. PubMed ID: 6422952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antibacterial activity of 6- and 7-[2-(5-carboxyimidazole-4-carboxamido)phenylacetamido]-penicillins and cephalosporins.
    Yasuda N; Iwagami H; Nakanishi E; Nakamiya T; Sasaki Y; Murata T
    J Antibiot (Tokyo); 1983 Mar; 36(3):242-9. PubMed ID: 6339459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli.
    Chong Y; Lee K; Kwon OH
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():21-9. PubMed ID: 8150765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
    Bartmann K; Tarbuc R
    Infection; 1982; 10(6):361-70. PubMed ID: 6818153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.
    Cullmann W; Dick W
    Eur J Clin Microbiol; 1985 Feb; 4(1):34-40. PubMed ID: 3872794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 Apr; 13(4):657-64. PubMed ID: 248268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modern beta-lactam antibiotics.
    Sykes RB; Bonner DP; Swabb EA
    Pharmacol Ther; 1985; 29(3):321-52. PubMed ID: 3915359
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of penicillinase-resistant penicillins to increase the susceptibility of gram-negative bacteria to antibiotics.
    Farrar WE; O'Dell NM; Krause JM
    Ann Intern Med; 1967 Oct; 67(4):733-43. PubMed ID: 4862467
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
    Curtis NA; Eisenstadt RL; Rudd C; White AJ
    J Antimicrob Chemother; 1986 Jan; 17(1):51-61. PubMed ID: 3485092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenems: special properties contributing to their activity.
    Neu HC
    Am J Med; 1985 Jun; 78(6A):33-40. PubMed ID: 3873871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
    Pulverer G; Peters G; Kunstmann G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on synergistic action against penicillin and cephalosporin resistant bacteria. I: laboratory studies].
    Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1970 May; 61(5):463-72. PubMed ID: 4912970
    [No Abstract]   [Full Text] [Related]  

  • 38. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Netilmicin: its in vitro activity and synergism with penicillin compounds.
    Thadepalli H; Roy I
    Chemotherapy; 1980; 26(1):12-20. PubMed ID: 7353438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.